The New England biotech hub has been on a roll the past couple years, with the breakout success of Vertex Pharmaceuticals, the ongoing revival at Biogen Idec, Sanofi's $20 billion acquisition of Genzyme, and the continuing concentration of Big Pharma R&D in Boston. But both the science and business of biotech move fast. So which companies, and which entrepreneurs, are the ones to watch for the next five to 10 years? We'll have keynotes from two of Boston's biotech leaders. We'll hear from the CEOs of five biotech startups that are gaining traction in the industry. And we'll have an interactive panel discussion about an important but sometimes overlooked source of startup funding: grants from non-profit disease foundations. Join us for this extraordinary gathering of up-and-comers in the New England biotech hub.
George Scangos, CEO, Biogen Idec
Mark Levin, Partner, Third Rock Ventures
Chip Clark, CEO, Genocea
Doug Fambrough, CEO, Dicerna
Tillman Gerngross, CEO, Adimab
Joanna Horobin, CEO, Syndax
Joseph Yanchik, CEO, Aileron
Louise Perkins, Chief Scientific Officer, Multiple Myeloma Research Foundation
Julia L. Greenstein, Assistant Vice President, Cure Therapies, Juvenile Diabetes Research Foundation
Rick Winneker, SVP, Leukemia & Lymphoma Society
Michael Kauffman, CEO, Karyopharm
Jens Eckstein, President, SR One
Doug Williams, Executive Vice President, Research and Development, Biogen Idec
Tuan Ha-Ngoc, CEO, Aveo Pharmaceuticals
Registration: 12:30 – 1:30 pm
Program: 1:30 – 5:30 pm
Networking Reception: 5:30 – 6:30 pm
Tickets are transferable but not refundable.
To inquire about press registration, e-mail email@example.com.
Alexandria Real Estate Equities
Cubist Pharmaceuticals • Guard Dog Brand Development
Halloran Consulting Group• Kauffman Foundation • Latham & Watkins
MFA-Moody Famiglietti & Andronico • SRI International • Turnstone • UK Trade & Investment
VENTURE CAPITAL MEMBERS
Advanced Technology Ventures • ARCH Venture Partners • Atlas Venture
Avalon Ventures • Bain Capital Vantures • Boston Millennia Partners
Flagship Ventures • North Bridge Venture Partners • Polaris Venture Partners • SR One
When & Where
Xconomy is an innovative news and events organization with outposts in Boston, Boulder/Denver, Detroit/Ann Arbor, New York, Raleigh-Durham, San Diego, San Francisco, Seattle, Texas, and Wisconsin. It is dedicated to providing business and technology leaders with timely, insightful, close-to-the-scene information about the local personalities, companies, and technological trends that best exemplify today’s high-tech economy. Xconomy is staffed by world-class journalists and media professionals, and supported by “the Xconomists,” who include some of the world’s leading innovators. Get to know them and the Xconomy team at www.xconomy.com/about.
Sign up for RSS feeds, daily email newsletters, and email alerts from Xconomy at http://www.xconomy.com/rss-feeds/.